viernes, 23 de agosto de 2024
Drug Trials Snapshots: PIASKY (crovalimab-akkz)
PIASKY is a prescription drug that is a complement C5 inhibitor used to treat adult and pediatric patients 13 years and older with a disease called paroxysmal nocturnal hemoglobinuria (PNH) and body weight of at least 40 kg.
PNH is a serious, life-threatening disease which is characterized by destruction of red blood cells (hemolysis), blood clots (thrombosis), and bone marrow dysfunction due to the overactivation of the complement system, a part of the body’s immune system.
https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-piasky
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario